Form 4 for SUPN SUPERNUS PHARMACEUTICALS, INC.
Accepted 2023-04-10 00:00:00 ET · period of report 2023-03-14 · accession 0001104659-23-043635 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-10 | 2023-03-14 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | M - OptEx | $0.00 | +1,500 | 2,841 | +112% | $0 |
| D | 2023-04-10 | 2023-03-14 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | F - Tax | $38.65 | -789 | 2,052 | -28% | -$30.5K |
| D | 2023-04-10 | 2023-03-14 | SUPN | DEC TIMOTHY C | CFO, Senior Vice-Pres | M - OptEx | $0.00 | -1,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-14 | M | A | 1,500 | $0.00 | 2,841 | D | — | — | (F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022. |
| 2 | Common | Common Stock | 2023-03-14 | F | D | 789 | $38.65 | 2,052 | D | — | — | (F2) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the PSU vesting. |
| 3 | Derivative | Performance Share Unit | 2023-03-14 | M | D | 1,500 | $0.00 | 0 | D | $0.00 · — to — | 1,500 Common Stock | (F1) Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on May 3, 2022. (F3) On May 3, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period. |